FIV Envelope Antibody (CE4-13B1 (13B1)) [PE/Cy5.5]

• Reactivity: V-Vi
• Applications: Flow
• Clone: CE4-13B1 (13B1)
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: PE/Cy5.5

FIV Envelope Antibody (CE4-13B1 (13B1)) [PE/Cy5.5] Summary

• Immunogen: Purified gp95 envelope antigen.
• Specificity: NB100-66553 is specific for FIV Envelope gp95 protein. This antibody is directed against an epitope within the variable V2 region and cross-reacts with Petaluma, 34TF10, Ppr, MCH5-5 and Glasgow 8 isolates. NB100-66553 does not neutralize FIV and does not recognize Feline Leukaemia Virus, Feline Herpes Virus Type 1, Feline Coronavirus and Feline Calicivirus.
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein A purified

Applications/Dilutions

• Dilutions:
  • Flow Cytometry
• Application Notes: Optimal dilution of this antibody should be experimentally determined. For optimal results using our Tandem dyes, please avoid prolonged exposure to light or extreme temperature fluctuations. These can lead to irreversible degradation or decoupling. When staining intracellular targets, specific attention to the fixation and permeabilization steps in your flow protocol may be required. Please contact our technical support team at technical@novusbio.com if you have any questions.

Reactivity Notes

Viral.

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark. Do not freeze.
• Buffer: PBS
• Preservative: 0.05% Sodium Azide
• Purity: Protein A purified

Background

The lentivirus FIV, responsible for a progressive and debilitating immune deficiency syndrome in domestic cats, similar to that caused by the human Immunodeficiency Virus (HIV), is a complex retrovirus with a tightly-packed genome, containing the structural genes gag, env and pro-pol and the accessory genes vif, rev and ORF-A/2.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.